PCOS Treatment Options in India: A Step-by-Step Guide

• PCOS treatment is goal-led, not one-size-fits-all — your plan depends on whether you want regular cycles, clearer skin, fertility, or lower long-term metabolic risk.
• Lifestyle changes that improve insulin sensitivity are the foundation of every plan and make every medication work better at lower doses.
• Metformin and inositol target insulin resistance; the pill and anti-androgens manage cycles, acne and excess hair; letrozole leads fertility treatment.
• PCOS is lifelong, so the aim is sustained control and review every 6–12 months — not a cure.
• Going many months without a period needs attention even if you are not trying to conceive, because it can thicken the uterine lining over time.
• Mental health, metabolic monitoring and culturally familiar add-ons like yoga and certain herbs all have a real place when used alongside medical care.

PCOS treatment is goal-led, not diagnosis-led. The same diagnosis in two women can mean very different prescriptions — one wants regular cycles and clearer skin, another wants to conceive, and a third is mainly worried about long-term diabetes risk. International and Indian guidance (the international PCOS guideline updated in 2023, and FOGSI's consensus) starts by asking what matters most to you, then builds the plan around that goal.

Almost every PCOS plan rests on a shared base: lifestyle changes that improve insulin resistance. On top of that, your gynaecologist or endocrinologist layers in medication depending on your priority — cycle regulation, acne and hirsutism, fertility, or metabolic protection. Some women need only the foundation; many need one or two add-ons; a few need the full stack.

PCOS is a lifelong condition. The aim is not a cure but sustained control — fewer missed cycles, calmer skin, easier weight regulation, and a lower long-term risk of type 2 diabetes, high blood pressure and endometrial (uterine lining) changes. Reviews every six to twelve months are the norm, not the exception. These regular reviews keep the plan matched to how your hair, weight, mood and cycles are actually doing year to year.

• A 5–10% reduction in body weight, in women with overweight or obesity, restores ovulation in roughly half of cases and improves insulin sensitivity, lipids and androgen levels. This is a clinical target, not a cosmetic one — and it does not apply to lean women, who can have PCOS at a healthy weight.
• Strength training two to three times a week matters as much as cardio, because muscle is the body's largest insulin sink. Adding even 30 minutes of resistance work weekly often lowers fasting insulin faster than steady-state cardio alone.
• Carbohydrate quality matters more than quantity. Swap white rice and maida for hand-pounded rice or millets, add a fist of protein and a palm of vegetables at every meal, and keep added sugar low. For a deeper dive, see what actually works in an anti-PCOS diet.
• Sleep under six hours and chronic stress both raise insulin resistance and worsen symptoms; a regular bedtime and a short daily wind-down are part of the treatment, not optional extras.
• Lifestyle does not replace medication in moderate-to-severe PCOS, but it amplifies every other treatment — women who hold the foundation usually need lower doses of metformin or inositol and report fewer side effects.

Metformin (sold in India as Glycomet, Obimet, Glyciphage) is the most-prescribed PCOS medication in the country. It is technically a type 2 diabetes drug, but in PCOS it works by lowering insulin resistance — the engine that drives androgen excess, irregular cycles and weight gain.

Typical starting doses are 500 mg once daily with the largest meal, titrated up over two to four weeks to 1500–2000 mg in divided doses. The slow ramp is deliberate: it limits the gut side effects (nausea, bloating, loose stools) that make many women quit in the first week. Extended-release versions (Glycomet SR, Glyciphage SR) are gentler on the stomach and worth asking about if standard metformin upsets you.

Cost is among the lowest of any chronic medication in India — roughly 50–300 rupees a month. Most generics are bioequivalent, so brand choice is rarely clinically significant.

Metformin causes only modest weight loss on its own (typically 2–4 kg over six to twelve months); the popular belief that it is a weight-loss drug is overstated. Its real value is restoring ovulation in some women, improving cycle regularity, and lowering the long-term risk of progressing to type 2 diabetes. Long-term use can deplete vitamin B12, so an annual B12 level is now considered standard of care.

Metformin is generally regarded as safe in pregnancy and is often continued through the first trimester in women who conceived on it; this is individualised and should be reviewed with your OB-GYN.

Inositol is a vitamin-like compound that, in two specific forms — myo-inositol and d-chiro-inositol — helps the body use insulin more efficiently. Randomised trials and a Cochrane review suggest it can improve menstrual regularity, ovulation and metabolic markers in PCOS, with a side-effect profile far gentler than metformin.

The form that matters most is a 40:1 ratio of myo-inositol to d-chiro-inositol, mirroring the natural proportion in healthy ovaries. Indian brands supplying this ratio include Inofolic Alpha, PCOSofy, Velositol and OvaBless; expect to pay roughly 500–1500 rupees a month. Cheaper single-form myo-inositol powders work less reliably and are not a first choice.

Typical dosing is two grams of myo-inositol plus 50 mg of d-chiro-inositol, twice a day with meals. Most women notice cycle changes by month three; give it at least six months before judging the response.

Inositol pairs well with metformin and lifestyle, and is often used as a metformin alternative in women who cannot tolerate the gut side effects, or who want a gentler first step. It is also commonly used in fertility preparation, including before IVF, for its small but consistent benefit on egg quality.

Inositol is not a quick fix and does not replace medical care in severe insulin resistance, but for mild-to-moderate PCOS it is a credible, well-tolerated tool that has earned its place on the ladder.

• Combined pills work by suppressing the abnormal hormonal signalling from the brain and lowering free testosterone in circulation, which is why they help both cycles and skin.
• Indian OB-GYNs commonly prescribe Krimson 35 and Diane 35 (cyproterone acetate plus ethinyl estradiol), and Yaz or Yasmin (drospirenone plus ethinyl estradiol). Krimson 35 and Diane 35 have the strongest anti-androgen effect and are often chosen when acne or facial hair is the dominant complaint. Costs typically run 200–800 rupees a month.
• Beyond cycle regulation, OCPs protect the endometrium. Going many months without a period lets the uterine lining thicken, which raises the long-term risk of endometrial hyperplasia and cancer; a scheduled monthly withdrawal bleed resets the lining.
• OCPs are not for everyone. Contraindications include a personal or strong family history of clots, uncontrolled hypertension, migraine with aura, active liver disease, and smoking over age 35. Disclose your full history at the consultation.
• If combined pills are not an option, a progesterone-only approach (oral progestin for ten days every one to three months, or a hormonal IUD like Mirena) can protect the lining without the oestrogen exposure.
• OCPs manage PCOS symptoms while you take them; they do not cure the condition. The underlying pattern returns within weeks of stopping, which is why they are layered with the lifestyle foundation rather than used as a standalone fix.

Spironolactone is the most commonly prescribed anti-androgen in India for PCOS-related acne, excess facial and body hair and scalp hair thinning. Originally a blood-pressure drug, at PCOS doses (50–100 mg twice daily) it blocks androgen receptors in skin and hair follicles. Generic versions cost roughly 200–500 rupees a month.

Visible improvement takes time: most women see meaningful change in acne by month three and in hirsutism by month six to nine. Patience is part of the prescription. Spironolactone is often combined with an OCP, both to multiply the anti-androgen effect and to guarantee contraception — it can cause feminisation of a male foetus if pregnancy occurs while taking it, so reliable contraception is non-negotiable.

Finasteride (1 mg or 2.5 mg daily) is used off-label for severe scalp hair loss or hirsutism that does not respond to spironolactone. It carries the same pregnancy contraindication and is usually started by a dermatologist or endocrinologist. For the bigger picture on scalp thinning, see PCOS hair loss and female-pattern alopecia.

Topical eflornithine cream (where available) slows facial hair regrowth and is often layered with laser or intense pulsed light treatment for visible results within six months. For a full skin-focused plan, see PCOS acne treatment options.

Anti-androgens are not appropriate if you are actively trying to conceive — in that case the conversation shifts to ovulation induction. They are also not first-line for mild cosmetic concerns where lifestyle and an OCP may be enough.

• Letrozole (Femara, Letoval; roughly 200–600 rupees per cycle) is now first-line for ovulation induction in PCOS, after trials and guideline updates showed higher live-birth rates than clomiphene citrate.
• Clomiphene citrate (Clomid, Fertomid; around 100–300 rupees per cycle) remains widely used in India, particularly at smaller centres, and is a reasonable second-line option when letrozole is unavailable or has failed.
• Metformin is often added to ovulation induction, especially with significant insulin resistance or a high BMI, as it modestly improves ovulation and reduces the risk of overstimulation.
• If three to six cycles of oral induction do not result in pregnancy, the next step is typically gonadotropin injections with intrauterine insemination (IUI) — more expensive (about 8,000–30,000 rupees per cycle in private clinics) and requiring close monitoring.
• IVF is the final step for women who do not respond to oral or injectable induction, or who have additional fertility factors. A single cycle in India typically costs 1.5–3 lakh rupees; PCOS responds well to IVF but carries a higher risk of ovarian hyperstimulation, so protocols are adjusted.
• Before starting any treatment, basic groundwork helps: see Trying to Conceive 101 for the pre-conception checklist, and don't skip thyroid testing, vitamin D and a partner semen analysis. For what conception, higher-risk monitoring and pregnancy look like with PCOS specifically, see PCOS and pregnancy.

Bariatric surgery (most commonly sleeve gastrectomy in India) is considered in women with PCOS and a BMI above 35 with at least one significant metabolic complication — type 2 diabetes, severe sleep apnoea, fatty liver disease, or treatment-resistant hypertension. For Indian populations, some specialists use a slightly lower threshold of 32–33, because Indians tend to develop metabolic disease at lower body weights than Western populations.

The metabolic improvements can be striking: ovulation often returns within months, insulin resistance drops sharply, and many women either come off PCOS medication or significantly reduce their doses. Fertility frequently returns even without further treatment.

In India, sleeve gastrectomy at a reputable private hospital typically costs 2–4 lakh rupees; gastric bypass is more expensive. Many insurance plans now cover bariatric surgery when metabolic indications are documented.

Surgery is not a shortcut. It requires lifelong follow-up — micronutrient supplementation, dietary change and routine bloodwork — and is preceded by months of evaluation by a multidisciplinary team. Pregnancy is usually discouraged for the first 12–18 months while weight stabilises.

It is rarely the first conversation a gynaecologist will have with you. Bariatric surgery belongs on the menu, but well down the ladder — after lifestyle, medication and a sober conversation about long-term metabolic risk.

Depression and anxiety occur at roughly two to three times the rate in women with PCOS compared to the general population — a pattern seen in Indian studies too. Some of this is hormonal; much of it is the cumulative weight of cycle unpredictability, acne, weight struggles and the social pressure that lands disproportionately on women in India.

Treating the mental-health side is part of treating PCOS, not a side quest. Screening for depression and anxiety should happen at every annual review; if you are struggling, name it during the consultation rather than waiting to be asked. The link between hormones and mood is real and worth naming early.

Talk therapy (CBT in particular) has good evidence in PCOS for reducing depressive symptoms and improving body image. SSRIs (commonly sertraline, escitalopram, fluoxetine in India) are safe and effective when therapy alone is not enough. A psychiatrist consultation in a metro typically costs 800–2000 rupees, and many tele-mental-health services now offer this at lower cost — our guide to depression and anxiety treatment and where to get help maps the options.

Peer support — online PCOS communities, in-person groups, or a sister or friend who lives with it too — repeatedly comes up in Indian patient surveys as one of the most protective factors against burnout.

If acne, hirsutism or weight changes are eroding your sense of self, that is a clinical concern, not a vanity one. A plan that addresses both the physical and the emotional load is more sustainable than treating one and ignoring the other.

Many Indian women weave Ayurvedic herbs and practices into their PCOS care, and a respectful, evidence-based view recognises both the genuine benefits and the real limits.

Herbs with reasonable supporting evidence in PCOS include cinnamon (improves insulin sensitivity), fenugreek seed extract (modest improvements in cycle regularity) and spearmint tea (a small but measurable reduction in androgen levels and hirsutism). Yoga, particularly regular suryanamaskar and supta baddha konasana, has been shown in Indian trials to improve cycle frequency and reduce stress markers.

The limits matter equally. No Ayurvedic protocol has been shown to replace metformin, inositol or letrozole for moderate-to-severe PCOS. Be cautious of clinics promising a complete cure in three months, especially those combining herbal mixes with unlabelled hormones or steroids — these have caused real harm in Indian patient reports.

The best approach is integration, not substitution: keep your gynaecologist or endocrinologist as the primary lead, and add Ayurvedic or yoga elements that complement rather than replace medical treatment. Tell both sides what the other has prescribed; herb-drug interactions are real, especially with metformin and the OCP.

For a deeper, balanced view, see Ayurveda for PCOS.

• Fasting glucose, HbA1c and ideally a fasting insulin level once a year. Indian women with PCOS have a substantially elevated lifetime risk of type 2 diabetes, and early detection allows early intervention.
• Lipid profile (total cholesterol, LDL, HDL, triglycerides) once a year, more often if already abnormal.
• Blood pressure at every clinic visit; hypertension risk is higher in PCOS independent of weight.
• Endometrial review: if you go more than three to four months without a period, your gynaecologist may order a pelvic ultrasound to check endometrial thickness, especially after age 30.
• Vitamin B12 annually if you are on long-term metformin; vitamin D once a year for all women, given how widespread deficiency is in India.
• Mental-health screen at each annual review, with a low threshold for referral to a psychologist or psychiatrist.
• Annual review of the full medication list — what is still needed, what can be tapered, and whether changing life goals (TTC plans, weight changes) call for a different combination.

• For complex PCOS — severe insulin resistance, treatment-resistant cycles, or significant mental-health overlap — an endocrinologist or women's-health-trained internist is often a better lead than a general gynaecologist. In metros, a combined OB-GYN plus endocrinology team gives the most comprehensive care.
• In smaller towns, the first-line specialist is usually a general OB-GYN, who can manage most PCOS well. Ask for a referral if symptoms are not improving after six months on a stable regimen.
• Myth: weight loss alone fixes PCOS. Mostly true in mild cases with overweight, but many lean women have PCOS too, and medication or supplements are often still needed even after weight goals are met.
• Myth: PCOS treatment only matters if you are trying to conceive. False — cycle regulation, endometrial protection, metabolic monitoring and acne or hirsutism care all matter regardless of fertility plans.
• Myth: metformin is a weight-loss drug. Mostly false; its weight effect is modest, with lifestyle and strength training as the real engine of weight change.
• Myth: there is one definitive PCOS test. False. Diagnosis uses the Rotterdam criteria — at least two of three among irregular cycles, clinical or biochemical androgen excess, and polycystic ovaries on ultrasound. No single blood test confirms or rules out PCOS.
• Government and large private hospitals often run subsidised PCOS clinics; ask at the OB-GYN OPD or check your district hospital. Telemedicine has made specialist access much easier in tier-2 and tier-3 cities since 2020.

• You have gone three to four months or more without a period — this needs review to protect the uterine lining, even if you are not trying to conceive.
• You have very heavy, prolonged or unexpected bleeding, or bleeding between periods, which should always be assessed.
• Acne, facial or body hair, or scalp hair loss is worsening quickly, or new male-pattern features (a deeper voice, severe hair growth) appear — rapid change needs evaluation to rule out other causes.
• You notice darkened, velvety skin folds (acanthosis nigricans), strong thirst, frequent urination or unexplained fatigue, which can signal insulin resistance or diabetes.
• You have been trying to conceive for 12 months (or 6 months if you are over 35, or sooner if your cycles are very irregular) without success.
• Your mood, anxiety or body image is significantly affecting daily life — this deserves care as much as any physical symptom.

• Name your top one or two priorities for this year — cycle regularity, clearer skin, lower diabetes risk, or fertility — and bring that to your next OB-GYN appointment as the anchor of the conversation.
• Confirm the lifestyle foundation is in place: strength training twice a week, an honest look at sleep and stress, and a meal pattern your dietitian or gynaecologist endorses. Medications work better when the foundation is solid.
• Ask explicitly about metformin or inositol if you have insulin-resistance signs; about OCPs if cycles or acne are the main complaint; and about anti-androgens if hirsutism is the main complaint.
• Book the annual labs above on a single morning to make them easy to remember; many private labs in India bundle these as a PCOS panel for 1,000–2,000 rupees.
• Build a small support layer: one friend who knows, one online community you trust, and a therapist on call if your mood dips. PCOS is a marathon, and the people around you are part of the treatment plan.

• WHO — Polycystic ovary syndrome fact sheet
• International evidence-based guideline for the assessment and management of PCOS (2023)
• NHS — Polycystic ovary syndrome: Treatment
• ACOG — Polycystic Ovary Syndrome (PCOS) FAQ
• Cochrane — Inositol for subfertile women with PCOS